BTIG Names Guardant Health Top Pick for 2026
GH Guardant Health Inc
$158.78 +5.24%
View chart & analysis → - 1BTIG named Guardant Health a top pick for 2026, maintaining a buy rating and a price target of $210.
- 2Guardant's third-quarter revenue of $361 million increased 36% year-over-year, exceeding BTIG's expectations.
- 3Guardant Health raised its 2026 revenue outlook to a range between $1.36 billion and $1.37 billion.
So what's the key point?
Guardant Health's revenue grew more than experts expected. As the company raised its future revenue projections, analysts expect the stock to rise further.
Source Investing.com · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.